BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/13/2021 12:57:54 PM | Browse: 19 | Download: 21
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 64633
Country/Territory China
2021-03-01 11:43
Peer-Review Started
2021-03-01 11:50
To Make the First Decision
Return for Revision
2021-06-16 02:11
2021-06-30 04:17
Second Decision
2021-08-03 03:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-08-03 09:23
Articles in Press
2021-08-03 09:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-08-16 09:48
Typeset the Manuscript
2021-10-08 02:07
Publish the Manuscript Online
2021-10-13 12:57
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Minireviews
Article Title Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions
Manuscript Source Invited Manuscript
All Author List Xiao-Wan Bo, Li-Ping Sun, Song-Yuan Yu and Hui-Xiong Xu
Author(s) ORCID Number
Xiao-Wan Bo http://orcid.org/0000-0001-9879-7115
Li-Ping Sun http://orcid.org/0000-0002-4301-4520
Song-Yuan Yu http://orcid.org/0000-0003-3563-1884
Hui-Xiong Xu http://orcid.org/0000-0002-8699-854X
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81801802
National Natural Science Foundation of China 81725008
Shanghai Municipal Health Commission 2019LJ21
Shanghai Municipal Health Commission SHSLCZDZK03502
Science and Technology Commission of Shanghai Municipality 19DZ2251100
Science and Technology Commission of Shanghai Municipality 19441903200
Science and Technology Commission of Shanghai Municipality 18441905500
Shanghai “Rising Stars of Medical Talent” Youth Development Program
Corresponding Author Hui-Xiong Xu, PhD, Doctor, Department of Medical Ultrasound, Shanghai Tenth People’s Hospital; Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, Cancer Center, Tongji University School of Medicine; Shanghai Engineering Research Center of Ultrasound Diagnosis and Treatment; National Clinical Research Center for Interventional Medicine, No. 301 Yanchangzhong Road, Shanghai 200072, China. xuhuixiong@126.com
Key Words Hepatocellular carcinoma; Thermal ablation; Radiofrequency ablation; Immunotherapy; Recurrence; Anti-tumor immune response
Core Tip Hepatocellular carcinoma (HCC) is one of the most leading causes of death in the world. Thermal ablation (TA) is an important treatment method for HCC patients. The main disadvantage of TA for HCC is the high local and distant recurrence rates after treatment. Immunotherapy is a novel systemic treatment that presents potential efficacy to inhibit the tumor recurrence. The combination of local TA and immunotherapy for HCC may be an ideal treatment for enhancing the efficacy of TA and controlling the recurrence. We herein summarize the latest progress in TA, immunotherapy, and the combination of TA with immunotherapy for HCC and discuss the future directions of the combined therapy.
Publish Date 2021-10-13 12:57
Citation Bo XW, Sun LP, Yu SY, Xu HX. Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions. World J Gastrointest Oncol 2021; 13(10): 1397-1411
URL https://www.wjgnet.com/1948-5204/full/v13/i10/1397.htm
DOI https://dx.doi.org/10.4251/wjgo.v13.i10.1397
Full Article (PDF) WJGO-13-1397.pdf
Full Article (Word) WJGO-13-1397.docx
Manuscript File 64633_Auto_Edited-JPY_WangTQ.docx
Answering Reviewers 64633-Answering reviewers.pdf
Audio Core Tip 64633-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 64633-Conflict-of-interest statement.pdf
Copyright License Agreement 64633-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 64633-Grant application form(s).pdf
Peer-review Report 64633-Peer-review(s).pdf
Scientific Misconduct Check 64633-Bing-Gong ZM-1.png
Scientific Misconduct Check 64633-Scientific misconduct check.pdf
Scientific Editor Work List 64633-Scientific editor work list.pdf